Surgalign Announces Third Clinical Site in the Commercialization of its HOLO Portal™ Surgical Guidance System
Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical
technology company focused on elevating the standard of care by
driving the evolution of digital health, today announced further
advancement in the commercialization of its HOLO Portal™ surgical
guidance system. The Company is pleased to report that Jaideep
Chunduri, MD, a board certified orthopaedic and spinal surgeon at
Beacon Orthopedics & Sports Medicine in Cincinnati, Ohio,
performed his first case with the HOLO Portal surgical guidance
HOLO Portal, the world’s first surgical guidance system to
incorporate AI and AR, represents the initial clinical application
of Surgalign’s HOLO™ AI digital health platform. The system’s AI
processes intraoperative images to autonomously segment and label
the anatomy and plan patient-specific pedicle screw trajectories
that are approved by the surgeon. The HOLO Portal system uses AR to
overlay the segmented AI reconstruction over the patient’s actual
anatomy, providing real-time 3D visualization throughout the
surgical procedure. This AR display helps surgeons visualize
trajectories and guide surgical instruments.
“The fidelity of the holographic surgical display is quite
amazing, and the AI planned screws were right where I wanted them.
HOLO Portal is truly next-generation technology, and even better it
is straightforward and intuitive to adopt into a surgical
technique,” stated Dr. Chunduri, who joined Beacon Orthopedics
& Sports Medicine in 2003. “Artificial intelligence and
augmented reality promise to make surgery more efficient and safer,
which is ultimately why I chose to integrate HOLO Portal into my
In January 2022, the Company received U.S. Food & Drug
Administration (FDA) 510(k) clearance for use of the HOLO Portal
surgical guidance system within lumbar spine procedures. The
Company is currently expanding the system’s limited market release
and intends to further increase site locations throughout the year.
As cases are performed and data is accumulated, the Company plans
to integrate new applications on its platform with the goal to both
advance the quality of care and improve outcomes for patients.
“Congratulations to Dr. Chunduri for completing his first
surgical case with the SurgalignTM HOLO Portal system,” said Terry
Rich, President and CEO of Surgalign. “The performance to date of
the HOLO Portal system and the surgeon excitement generated by the
technology have validated our high expectations. We believe that
our HOLO AI technology will transform patient outcomes, and we
couldn’t be prouder to partner with Dr. Chunduri.”
About Surgalign Holdings, Inc.Surgalign
Holdings, Inc. is a global medical technology company committed to
the promise of digital health to drive transformation across the
surgical landscape. Uniquely aligned and resourced to advance the
standard of care, the company is building technologies physicians
and other health providers will look to for what is truly possible
for their patients. Surgalign is focused on developing solutions
that predictably deliver superior clinical and economic outcomes.
Surgalign markets products throughout the United States and in
approximately 50 countries worldwide through an expanding network
of top independent distributors. Surgalign is headquartered in
Deerfield, IL, with commercial, innovation and design centers in
San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany.
Learn more at www.surgalign.com and connect on LinkedIn and
Forward Looking StatementThis press release
contains forward-looking statements based on management’s current
expectations, estimates and projections about our products,
company, and industry, our management's beliefs, and certain
assumptions made by our management. Words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
and other variations of such words and similar expressions are
intended to identify such forward-looking statements.
Forward-looking statements include statements regarding the
features, capabilities and benefits of the HOLO Portal system.
These statements are not guarantees of future performance and are
subject to risks and uncertainties, including the risks described
in our public filings with the U.S. Securities and Exchange
Commission (SEC). Our actual results may differ materially from the
anticipated results reflected in these forward-looking statements.
Copies of the company's SEC filings may be obtained by contacting
the company or the SEC or by visiting Surgalign's website
at www.surgalign.com or the SEC's website
Investor and Media Contact:
|+1 917 887 8434
||+1 619 206 4648
Historical Stock Chart
From Nov 2022 to Dec 2022
Historical Stock Chart
From Dec 2021 to Dec 2022